Last $9.26 USD
Change Today +0.27 / 3.00%
Volume 362.8K
SUPN On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William A. Nuerge

Director, Member of Compensation Committee and Member of Audit Committee, Supernus Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 2 different organizations across 5 different industries.

See Board Relationships
62$81,095

Background*

Mr. William A. Nuerge, also known as Bill, serves as a Managing Partner of Fortress Pharms Advisors, LLC. Mr. Nuerge served as the Chief Executive Officer of Xanodyne Pharmaceuticals, Inc., from November, 2004 to April 2007 and also served as its Consultant from March 2004 to November 2004. He has 30 years pharmaceutical industry experience and is noted for his high quality project management skills and his ability to identify talent, to motivate and to lead. He began ...

Read Full Background

Corporate Headquarters*

1550 East Gude Drive
Rockville, Maryland 20850

United States

Phone: 301-838-2500
Fax: --

Board Members Memberships*

2004-2007
Former Chief Executive Officer and Director
2006-Present
Director, Member of Compensation Committee and Member of Audit Committee

Education*

BS
Purdue University
Master's Degree
Purdue University
MBA
Indiana Wesleyan University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$38,000
Total Calculated Compensation$81,095
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SUPN:US $9.26 USD +0.27

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Alessandro E. Della Chà LL.MChief Executive Officer and Director
Cosmo Pharmaceuticals S.p.A.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUPERNUS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.